Evidence map›Paper›PMID 27467562›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2016

Vitamin D and bronchopulmonary dysplasia in preterm infants.

K E Joung, H H Burris, L J Van Marter, T F McElrath, Z Michael, P Tabatabai, A A Litonjua, S T Weiss, H Christou

Open access · hybridAbstract read
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Prenatal vitamin D supplementation mitigates inflammation-related alveolar remodeling in neonatal mice.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  6. Article
  7. Article
  8. [Expert consensus on the follow-up management of bronchopulmonary dysplasia in preterm infants after discharge].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  9. Vitamin D status in very low birth weight infants and response to vitamin D intake during their NICU stays: a prospective cohort study.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  10. Observational
  11. Review
  12. [Protective effect of vitamin D against hyperoxia-induced bronchopulmonary dysplasia in newborn mice].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Vitamin D and associated perinatal-neonatal outcomes among extremely low-birth-weight infants.Journal of perinatology : official journal of the California Perinatal Association · 2018
    Observational
  17. Review
  18. Article
  19. [Association between serum 25(OH)D levels at birth and bronchopulmonary dysplasia in preterm infants].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

K E JoungGoryeb Children's Hospital/Morristown Medical Center, Morristown, NJ, USA.
H H BurrisHarvard Medical School, Boston, MA, USA.
L J Van MarterHarvard Medical School, Boston, MA, USA.
T F McElrathHarvard Medical School, Boston, MA, USA.
Z MichaelHarvard Medical School, Boston, MA, USA.
P TabatabaiUniversity of Heidelberg, Heidelberg, Germany.
A A LitonjuaHarvard Medical School, Boston, MA, USA.
S T WeissHarvard Medical School, Boston, MA, USA.
H ChristouHarvard Medical School, Boston, MA, USA.
Brigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USBoston Children's Hospital · USHarvard University · USHeidelberg University · DEMorristown Medical Center · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood AsthmaU01HL091528 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LITONJUA, AUGUSTO A, WEISS, SCOTT T · 2009 to 2013
$10.0M
Vascular smooth muscle cell phenotypic switching in Pulmonary HypertensionR01HL116573 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHRISTOU, HELEN · 2014 to 2017
$1.7M
The Toxic Environment and the Epigenetics of Fetal GrowthK23ES022242 · NIEHS · CHILDREN'S HOSP OF PHILADELPHIA · PI BURRIS, HEATHER HERSON · 2013 to 2017
$790k
NCRR NIH HHS UL1 RR025758NHLBI NIH HHS R01 HL116573NHLBI NIH HHS U01 HL091528NIEHS NIH HHS K23 ES022242
6 · The paper itself

Abstract

objectiveVitamin D deficiency is associated with asthma and reactive airway disease in childhood but its potential contribution to bronchopulmonary dysplasia (BPD) in preterm infants is unknown. Preterm infants have lower levels of 25-hydroxyvitamin D (25(OH)D) at birth and are at risk for nutritional deficiencies after birth. The objective of the study was to evaluate the association of 25(OH)D concentrations at birth and at 36 weeks' corrected gestational age with BPD in preterm infants born before 29 completed weeks of gestation. STUDY

designWe collected umbilical cord blood samples from 44 preterm infants (gestational age <29 weeks) delivered at Brigham and Women's Hospital in Boston. In addition, with parental consent we collected venous samples at 36 weeks' corrected age from 20 preterm infants born before 29 weeks' gestation (including 6 infants with previously collected cord blood). Samples were frozen at -80 °C until subsequent measurement of 25(OH)D levels by chemiluminescence. We used multivariable logistic models to adjust for gestational age and considered other confounding variables, including maternal race, age, mode of delivery and infant sex.

resultsAmong 44 infants, 41 (93.2%) survived and 3 (6.8%) died before 36 weeks' corrected age. Median 25(OH)D levels at birth were 30.4 ng ml(-1) in preterm infants who subsequently died or developed BPD and 33.8 ng ml(-1) in infants who survived without BPD (P=0.6). Median 25(OH)D levels at corrected age of 36 weeks were 59.0 ng ml(-1) among survivors without BPD and 64.2 ng ml(-1) among survivors with BPD (P=0.9). Neither cord blood nor 36 weeks' corrected 25(OH)D levels were associated with odds of death or BPD (adjusted odds ratio (OR) 1.00, 95% confidence interval (CI): 0.73 to 1.37; and OR 0.93, 95% CI: 0.61 to 1.43, respectively).

conclusionsAmong this population of extremely preterm infants neither cord blood nor the 36 weeks' corrected age 25(OH)D levels were associated with development of BPD. Notably, at the current level of supplementation, all extremely preterm infants in our cohort had achieved 25(OH)D levels >30 ng ml(-1) by 36 weeks' corrected age, which is thought to represent sufficiency in adult and pediatric populations.

Indexed as

Bronchopulmonary DysplasiaFemaleGestational AgeHumansInfantInfant, NewbornInfant, PrematureInfant, Very Low Birth WeightLogistic ModelsMaleProspective StudiesVitamin DVitamin D Deficiency25-hydroxyvitamin DVitamin D

Identifiers

PMID27467562
PMCPMC5045784
OpenAlexW2475431160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.